NeuroTrials Research

Executive Summary

NeuroTrials Research is a private clinical trial site headquartered in Atlanta, Georgia, established in 1998. Specializing in neuroscience, it conducts early- to late-phase studies for pharmaceutical and device companies, leveraging a network of experienced investigators. The company recruits volunteers from the Atlanta metropolitan area and the Southeastern US for trials addressing neurological, psychiatric, and sleep disorders. As a multi-specialty center, it plays a critical role in the clinical development pipeline for central nervous system (CNS) therapies. With over two decades of operation, NeuroTrials Research is well-positioned to benefit from the growing demand for CNS clinical trials, particularly in Alzheimer's, depression, and insomnia. However, as a private site without disclosed financials or a public pipeline, its visibility is limited. Upcoming catalysts include potential new trial awards, expansion into emerging therapeutic areas like psychedelic-assisted therapy, and strategic partnerships with large pharmaceutical sponsors. These developments could enhance its reputation and patient recruitment capabilities, though specific timing and success probabilities remain uncertain.

Upcoming Catalysts (preview)

• Q4 2026Award of Major Phase III Trial in Alzheimer's Disease60% success
• Q1 2027Expansion into Psychedelic-Assisted Therapy Trials40% success
• Q3 2026Strategic Partnership with Top-20 Pharma for CNS Portfolio50% success